Clinic News Latest in CardiologyACC Practice Made Perfect: Building Sustainable, Empowering PlatformsIn this episode, hosted by the ACC Women in Cardiology (WIC) Advocacy Work Group, Drs. Kamala Tamirisa and Keerthana Pakanati welcome distinguished guests Drs. Lipi Roy and Amit Goyal to explore innovative strategies in cardiovascular education, media engagement, and leadership empowerment.FDA Update: Philips Recalls Tack Endovascular SystemsThe U.S. Food and Drug Administration (FDA) announced on March 3 that Philips is removing and discontinuing distribution of the Tack Endovascular System due to challenges necessitating additional procedures to retrieve or remove the implant.Sex-Based Analysis of Short-Term DAPT in Patients at High Bleeding Risk Undergoing PCIOne- and three-month dual antiplatelet therapy (DAPT) was found to have similar risk for ischemic events in both women and men at high bleeding risk undergoing PCI...DAPA-HF and DELIVER: Does Dapagliflozin Reduce Risk For Patients With Severe HF?Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF...Amyloidosis Forum: Imaging Endpoints in AL and ATTR Amyloidosis Clinical TrialsA new state-of-the-art review published March 5 in JACC: Cardiovascular Imaging summarizes a discussion by the Amyloidosis Forum on the role of imaging biomarkers as trial endpoints in the diagnosis and assessment of systemic immunoglobin light chain (AL) and transthyretin (ATTR) amyloidosis.What is the Cardiopulmonary Fitness Level of Children With Inherited Cardiac Disease?Cardiopulmonary fitness and physical activity levels were significantly lower in children with inherited cardiac disease than in healthy controls, according to a study published Feb. 25...ANDROMEDA Meta-Analysis: PCB Angioplasty vs. DES ImplantationIn patients undergoing PCI for de novo small-vessel coronary artery disease (SV-CAD), paclitaxel-coated balloon (PCB) angioplasty was associated with a reduction in the primary endpoint of major adverse cardiac events (MACE) ...Does Tafamidis Improve Survival For Octogenarians With Wild-Type Transthyretin Cardiac Amyloidosis?Tafamidis treatment in octogenarians diagnosed with wild-type transthyretin cardiomyopathy (ATTRwt-CM) improves survival without age affecting treatment efficacy, although mortality remains considerable, according to an international cohort study published Feb. 26...FINEARTS-HF Analysis Shows Finerenone Reduces Worsening HF Symptoms in OutpatientsPatients with heart failure (HF) who have worsening HF symptoms that require intensification of oral diuretics in the outpatient setting are common and associated with a poor prognosis, and finerenone reduced the need for intensifying diuretics...Identifying MI after PCI; Myocardial Fibrosis & Severe Aortic Valve Stenosis; Anticoagulation & Cancer DiagnosesIn this week’s View, Dr. Eagle looks at the optimal threshold for identifying a myocardial infarction (MI) after PCI.
